Ptc Therapeutics (PTCT) Profit After Tax (2016 - 2025)
Historic Profit After Tax for Ptc Therapeutics (PTCT) over the last 14 years, with Q3 2025 value amounting to $15.9 million.
- Ptc Therapeutics' Profit After Tax rose 11490.43% to $15.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $751.7 million, marking a year-over-year increase of 26586.97%. This contributed to the annual value of -$363.3 million for FY2024, which is 4202.16% up from last year.
- As of Q3 2025, Ptc Therapeutics' Profit After Tax stood at $15.9 million, which was up 11490.43% from -$64.8 million recorded in Q2 2025.
- Ptc Therapeutics' 5-year Profit After Tax high stood at $866.6 million for Q1 2025, and its period low was -$198.9 million during Q2 2023.
- Its 5-year average for Profit After Tax is -$66.1 million, with a median of -$126.7 million in 2022.
- In the last 5 years, Ptc Therapeutics' Profit After Tax tumbled by 9173.51% in 2021 and then soared by 104627.63% in 2025.
- Over the past 5 years, Ptc Therapeutics' Profit After Tax (Quarter) stood at -$143.3 million in 2021, then dropped by 19.28% to -$170.9 million in 2022, then rose by 8.83% to -$155.8 million in 2023, then surged by 57.71% to -$65.9 million in 2024, then skyrocketed by 124.13% to $15.9 million in 2025.
- Its Profit After Tax was $15.9 million in Q3 2025, compared to -$64.8 million in Q2 2025 and $866.6 million in Q1 2025.